HK1041207B - Ccr5抗體pa14 - Google Patents

Ccr5抗體pa14

Info

Publication number
HK1041207B
HK1041207B HK02102467.8A HK02102467A HK1041207B HK 1041207 B HK1041207 B HK 1041207B HK 02102467 A HK02102467 A HK 02102467A HK 1041207 B HK1041207 B HK 1041207B
Authority
HK
Hong Kong
Prior art keywords
monoclonal antibody
binds
fragment
antibody
ccr5 antibody
Prior art date
Application number
HK02102467.8A
Other languages
English (en)
Other versions
HK1041207A1 (en
Inventor
William C Olson
Paul J Maddon
Original Assignee
Progenics Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharm Inc filed Critical Progenics Pharm Inc
Publication of HK1041207A1 publication Critical patent/HK1041207A1/xx
Publication of HK1041207B publication Critical patent/HK1041207B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK02102467.8A 1998-12-16 2002-04-03 Ccr5抗體pa14 HK1041207B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21279398A 1998-12-16 1998-12-16
US11253298P 1998-12-16 1998-12-16
PCT/US1999/030345 WO2000035409A2 (en) 1998-12-16 1999-12-16 Hiv-i fusion inhibition compounds

Publications (2)

Publication Number Publication Date
HK1041207A1 HK1041207A1 (en) 2002-07-05
HK1041207B true HK1041207B (zh) 2007-12-28

Family

ID=26810060

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102467.8A HK1041207B (zh) 1998-12-16 2002-04-03 Ccr5抗體pa14

Country Status (13)

Country Link
EP (2) EP1144006B1 (zh)
JP (1) JP2002538771A (zh)
AT (1) ATE375802T1 (zh)
AU (3) AU773175B2 (zh)
CA (1) CA2355607A1 (zh)
CY (1) CY1107858T1 (zh)
DE (1) DE69937369T2 (zh)
DK (1) DK1144006T3 (zh)
ES (1) ES2296416T3 (zh)
HK (1) HK1041207B (zh)
MX (1) MXPA01006097A (zh)
PT (1) PT1144006E (zh)
WO (1) WO2000035409A2 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637890D1 (de) 1995-06-07 2009-05-14 Progenics Pharm Inc Monoklonaler antikörper für die inhibierung von hiv-1-hüllgykoprotein-vermittelte membranfusion
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2265701A (en) * 1999-12-16 2001-06-25 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
US7138119B2 (en) 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20020146415A1 (en) * 2001-04-06 2002-10-10 Olson William C. Methods for inhibiting HIV-1 infection
DE60203324T2 (de) * 2001-12-21 2006-04-06 Micromet Ag Einzelne und duale anti-cd4-rantes chemokin/zytokin konstrukte
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
IL163655A0 (en) * 2002-02-22 2005-12-18 Protein Design Labs Inc Anti-ccr5 antibody
TW200720289A (en) 2005-04-01 2007-06-01 Hoffmann La Roche Antibodies against CCR5 and uses thereof
CA2637463A1 (en) * 2006-01-30 2007-08-02 F. Hoffmann-La Roche Ag Synergistic compositions for treating hiv
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
WO2008019817A1 (en) 2006-08-17 2008-02-21 F. Hoffmann-La Roche Ag A conjugate of an antibody against ccr5 and an antifusogenic peptide
EP2074147B1 (en) 2006-09-29 2012-03-21 F. Hoffmann-La Roche AG Antibodies against ccr5 and uses thereof
TW200902544A (en) 2007-03-13 2009-01-16 Hoffmann La Roche Peptide-complement conjugates
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975749A2 (en) * 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
JP4183754B2 (ja) * 1996-06-14 2008-11-19 プロジェニクス・ファーマスーティカルス・インコーポレーテッド Ｈｉｖ―１感染を阻害するためのケモカイン受容体の使用
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
DK1144006T3 (da) 2007-11-26
CY1107858T1 (el) 2013-06-19
AU773175B2 (en) 2004-05-20
MXPA01006097A (es) 2002-04-15
AU2004205164A1 (en) 2004-09-16
ES2296416T3 (es) 2008-04-16
EP2088158A2 (en) 2009-08-12
ATE375802T1 (de) 2007-11-15
WO2000035409A2 (en) 2000-06-22
HK1041207A1 (en) 2002-07-05
WO2000035409A3 (en) 2000-09-14
DE69937369T2 (de) 2008-07-24
EP1144006A2 (en) 2001-10-17
DE69937369D1 (de) 2007-11-29
AU2004205165A1 (en) 2004-09-16
EP1144006B1 (en) 2007-10-17
CA2355607A1 (en) 2000-06-22
AU2199600A (en) 2000-07-03
JP2002538771A (ja) 2002-11-19
EP2088158A3 (en) 2010-01-20
PT1144006E (pt) 2007-12-11
EP1144006A4 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
CY1107858T1 (el) Ccr5 αντισωματα pa14
NZ616992A (en) Anti-ilt7 antibody
IL226637A0 (en) An isolated heterodimeric cytokine receptor
DE69429095T2 (de) Humanisierte antikoerper
IL124689A0 (en) Apoptosis induced by monoclonal antibody anti-her2
HK1115607A1 (en) Human cytokine receptor
NZ712762A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
GB9223377D0 (en) Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
ATE324381T1 (de) Mutiertes scfv-fragment des okt-3 antikörpers
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
CA2221893A1 (fr) Anticorps specifique de staphylococcus aureus et utilisations
AU6943800A (en) Antibodies specific for fullerenes
IL116617A0 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
NZ501990A (en) Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
MX9702422A (es) Anticuerpos recombinantes contra fas y adn para los mismos.
AU2707992A (en) Monoclonal antibodies to hepatitis c virus
SI1396501T1 (sl) Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr
DE59410219D1 (de) Monoklonale antikörper gegen ck-mb
CA2065797A1 (en) Monoclonal antibody, polypeptide and production thereof
EP0265156A3 (en) Monoclonal antibodies
EP0349258A3 (en) Method of determining the differentiation of a human t-cell
UA39209C2 (uk) Моноклональне антитіло, що інгібує хомінг кровотворних стовбурових клітин і розпізнає поверхневий антіген стромальної клітини селезінки, гібридома, яка його продукує
EP1734054A3 (en) Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
SE9501302D0 (sv) Antibodies for use in cancertherapy and diagnosis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111216